NBIX icon

Neurocrine Biosciences
NBIX

Overview Fund Activity

391 hedge funds and large institutions have $9.56B invested in Neurocrine Biosciences in 2019 Q4 according to their latest regulatory filings, with 109 funds opening new positions, 137 increasing their positions, 103 reducing their positions, and 41 closing their positions.

Holders
391
Holders Change
+59
Holders Change %
+17.77%
% of All Funds
7.72%
Holding in Top 10
8
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+14.29%
% of All Funds
0.16%
New
109
Increased
137
Reduced
103
Closed
41
Calls
$93.9M
Puts
$56.8M
Net Calls
+$37.1M
Net Calls Change
+$33.9M

Top Buyers

1
Renaissance Technologies
1
Renaissance Technologies
New York
$79.5M
2
BlackRock
2
BlackRock
New York
$709M
3
State Street
3
State Street
Massachusetts
$264M
4
T. Rowe Price Associates
4
T. Rowe Price Associates
Maryland
$784M
5
Ameriprise
5
Ameriprise
Minnesota
$36.6M

Top Sellers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$786M
2
Janus Henderson Group
2
Janus Henderson Group
United Kingdom
$793M
3
HM
3
HealthCor Management
New York
$86.7M
4
Wellington Management Group
4
Wellington Management Group
Massachusetts
$6.35M
5
O
5
OrbiMed
New York
$101M
Name Market Value Shares Shares
Change 		Shares
Change %
Vanguard Group
1
Vanguard Group
Pennsylvania
$894M 8,316,897 +100,511 +1%
Janus Henderson Group
2
Janus Henderson Group
United Kingdom
$793M 7,373,512 -1,130,024 -13%
Fidelity Investments
3
Fidelity Investments
Massachusetts
$786M 7,312,636 -1,316,144 -15%
T. Rowe Price Associates
4
T. Rowe Price Associates
Maryland
$784M 7,291,297 +560,937 +8%
BlackRock
5
BlackRock
New York
$709M 6,591,552 +655,434 +11%
Capital International Investors
6
Capital International Investors
California
$627M 5,832,143 +1,667 +0%
PA
7
Perceptive Advisors
New York
$388M 3,612,554 -447,346 -11%
BG
8
Bellevue Group
Switzerland
$357M 3,318,374 +19,900 +0.6%
State Street
9
State Street
Massachusetts
$264M 2,453,608 +626,052 +34%
Franklin Resources
10
Franklin Resources
California
$213M 1,983,499 +122,980 +7%
RSCM
11
Rock Springs Capital Management
Maryland
$137M 1,278,000 +45,500 +4%
BBA
12
Baker Bros. Advisors
New York
$135M 1,254,243 -161,040 -11%
AllianceBernstein
13
AllianceBernstein
Tennessee
$133M 1,239,933 -10,702 -0.9%
Invesco
14
Invesco
Georgia
$120M 1,118,437 -204,879 -15%
Geode Capital Management
15
Geode Capital Management
Massachusetts
$111M 1,035,230 +52,052 +5%
Deutsche Bank
16
Deutsche Bank
Germany
$105M 981,490 +86,768 +10%
O
17
OrbiMed
New York
$101M 935,970 -639,200 -41%
PAMU
18
Pictet Asset Management (UK)
United Kingdom
$92M 855,754 -185,246 -18%
Two Sigma Advisers
19
Two Sigma Advisers
New York
$89.3M 831,173 +98,200 +13%
HM
20
HealthCor Management
New York
$86.7M 806,864 -686,616 -46%
Norges Bank
21
Norges Bank
Norway
$84.5M 785,914 -70,697 -8%
Renaissance Technologies
22
Renaissance Technologies
New York
$79.5M 739,172 +735,272 +18,853%
Nuveen Asset Management
23
Nuveen Asset Management
Illinois
$74.4M 691,828 -115,889 -14%
Two Sigma Investments
24
Two Sigma Investments
New York
$72.2M 671,361 +273,598 +69%
DCP
25
DSM Capital Partners
Florida
$72.1M 670,549 +19,336 +3%
1
2 3 4 5